Navigation Links
SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY, DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS
Date:8/3/2009

SAN DIEGO, CA AND GENEVA, SWITZERLAND, August 3, 2009 /PRNewswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX), a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, and Firmenich SA, the world's largest privately-owned fragrance and flavor company, announced today that they have entered into a collaborative research, development, commercialization and license agreement for Senomyx's novel flavor ingredients intended to enhance the taste of sucrose (table sugar), fructose, and Rebaudioside (stevia).

During the collaborative period, Firmenich will have exclusive rights to commercialize selected Senomyx Sweet Enhancers worldwide in virtually all food product categories not currently licensed to other companies, and research costs will be shared. In return, Firmenich will pay to Senomyx license fees and royalties on sales of Sweet Enhancers developed under the collaboration. This new agreement does not impact Senomyx's existing collaborations with other companies on its Sweet Enhancer program or its other existing collaborations with Firmenich.

"Senomyx is excited about working with Firmenich to maximize the commercial potential of our new Sweet Enhancers," said Kent Snyder, President and Chief Executive Officer of the Company. "We believe there is a large market opportunity for these flavor ingredients, and it is a key goal for Senomyx to have our Sweet Enhancers introduced into the marketplace as quickly, broadly and efficiently as possible.

"Firmenich is a global leader in providing food ingredients and flavor systems to major consumer companies," Snyder noted. "Their strong full-service capabilities include product development, proprietary fo
'/>"/>

SOURCE Senomyx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. SENOMYX, INC. SECOND QUARTER 2009 EARNINGS CONFERENCE CALL SCHEDULED FOR AUGUST 4, 2009
2. SENOMYX ANNOUNCES APPOINTMENT OF DAVID L. LINEMEYER, PH.D., AS VICE PRESIDENT, BIOLOGY
3. SENOMYX ANNOUNCES FIRST QUARTER 2009 FINANCIAL RESULTS
4. SENOMYX ANNOUNCES NESTLES SELECTION OF A NEW FLAVOR INGREDIENT FOR EVALUATION OF COMMERCIAL POTENTIAL
5. SENOMYX, INC. FIRST QUARTER 2009 EARNINGS CONFERENCE CALL SCHEDULED FOR MAY 7, 2009
6. SENOMYX ANNOUNCES EXTENSION OF ITS COLLABORATION WITH CAMPBELL SOUP COMPANY
7. SENOMYX ANNOUNCES THE EXTENSION OF ITS COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT WITH AJINOMOTO CO., INC.
8. SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS
9. SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW BITTER BLOCKERS
10. SENOMYX, INC. fourth quarter AND FISCAL YEAR-END 2008 Earnings conference call scheduled for February 12, 2009
11. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 11TH ANNUAL NEEDHAM GROWTH STOCK CONFERENCE

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...R TOLEDO recently announced that Dr. Dominique Heb... of Process Analytical Technology (PAT) in Green C...1, 2009. , (PRWEB) Novemb...lytical Technology (PAT) in Green Chemistry and Gr...alytical Technology (PAT) case studies will be pre...
(Date:11/19/2009)...19 Dr. Mate Hidvegi, inventor of A...press release issued on November 17 by Biropharma ... false and self-serving statements about its U.S. ...i stated from his office in Budapest, Hungary: ,...does not apply to AveULTRA, www.aveultra.com , ...
(Date:11/19/2009)...WALTHAM, Mass., Nov. 19 Arlington ...d that the leading driver of antibiotic selection ...m activity against gram-positive and gram-negative...an cause nosocomial pneumonia, surveyed European p...ts that provide appropriate coverage against commo...
(Date:11/19/2009)...s Top Gene Synthesis Companies Form International ...t Practices in Risk Reduction ,Five Member Compa...sis Capacity , (PRWEB) No...ng gene synthesis companies today announced agreem...ol to promote biosecurity in the gene synthesis in...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...ion reagents , , D.J. Lowrie Jr. ,Depart...,University of Cincinnati College of Medicine, Cin...n cell lines is enhanced by the use of,liposome-...fficiency of green,fluorescent protein into huma...,transfection reagent and LipofectAMINE ,re...
...ter cell lines for signal transduction pathway rea...Mary Buchanan ,John Bauer Chao-Feng Zheng ,St... ,HLR-CREB, HLR-Elk1, and HLR-cJun, cell line...s that converge at the transcription,factors CRE...eature constitutive,expression of the GAL4-CREB,...
...ignal transduction pathways , , Li Xu Tim Sa...s, Inc. , Enhancer elements are the convergent p... pathways. For simple, rapid and convenient assess..., Stratagene has designed the PathDetect ,in vi...ms. Each of the cis-reporter,plasmids contains t...
Other Biology Technology:Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells 2Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells 3Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells 4Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion,Transactivators 2Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion,Transactivators 3Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion,Transactivators 4Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion,Transactivators 5Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion,Transactivators 6Signal Transduction Reporting Systems Using Cis-Acting Enhancer,Elements 2Signal Transduction Reporting Systems Using Cis-Acting Enhancer,Elements 3Signal Transduction Reporting Systems Using Cis-Acting Enhancer,Elements 4
(Date:11/19/2009)..., WALL, N.J., Nov. 19 BI...I), a leader in wireless public safety and finger-...d that the Special Shareholder Meeting held today ...se a quorum was not present. ,, (Logo: http://...,, While an impressive 99.3% of the 35 million ...
(Date:11/19/2009)...by Penn State,s Ross Hardison, T. Ming Chu Profess...n a large step toward unraveling how regulatory pr...ing development and growth. Working with collabora... at Children,s Hospital of Philadelphia, they focu...ng red blood cells (erythrocytes). These cells con...
(Date:11/19/2009)...ler, University of Cincinnati professor of paleont...and co-author Michael Foote of the University of C... of Science with their paper, "Epicontinental Se...s Extinction and Origination." , For many years,...tory of biodiversity have focused on charting the ...
Breaking Biology News(10 mins):BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3New research into the mechanisms of gene regulation 2New research into the mechanisms of gene regulation 3New research into the mechanisms of gene regulation 4New research into the mechanisms of gene regulation 5Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 2Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 3Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 4Media Alert 3A July 10 Run Miles for Special Smiles 47691 1Media Alert 3A July 10 Run Miles for Special Smiles 47691 2Photos 3A Philips Expands Home Healthcare Commitment With Portable Life Support Ventilator 3B Offers Ease of Use Portability and Versatility for Pati 47687 1Photos 3A Philips Expands Home Healthcare Commitment With Portable Life Support Ventilator 3B Offers Ease of Use Portability and Versatility for Pati 47687 2Photos 3A Philips Expands Home Healthcare Commitment With Portable Life Support Ventilator 3B Offers Ease of Use Portability and Versatility for Pati 47687 3ViroPharma to Present at Two June Healthcare Conferences 12426 1ViroPharma to Present at Two June Healthcare Conferences 12426 2
... LA JOLLA, Calif., April 9, 2009Scientists at Bur...the University of California San Diego (UC San Die...hat transplanted pancreatic precursor cells are pr...n polytetrafluorethylene (PTFE). The study, which ...s, was published online on April 8 in the journal ...
... Scientists have developed a new approach for sur...d by critical cell signaling pathways and regulate...rch, published by Cell Press in the April 10th iss...regulation of a previously uncharacterized protein...in cancer cell invasion. , Many cancers, includin...
... In the classic waterfall illusion, if you stare ...iod of time, stationary objects like rocks appea...that this phenomenon, called motion aftereffect, o...n our tactile perception, and that these senses ac... you feel the world can actually change how you se...
Other Biology News:Device protects transplanted pancreatic cells from the immune system 2New method for detection of phosphoproteins reveals regulator of melanoma invasion 2MIT: How you feel the world impacts how you see it 2
Monkey sP-selectin ELISA Kit from Bender MedSystems
Monkey sE-selectin ELISA Kit from Bender MedSystems
BioBank -80nullC Automated sample library management system from Thermo Scientific
BioBank -80nullC Automated sample library management system with CO2 backup from Thermo Scientific
Biology Products: